Tata Sons Set to Give Chandrasekaran a Third Term as Executive Chairman

access_time 2026-02-26T16:35:31.327Z face Baaten Bazar Ki (BBK)
Tata Sons Set to Give Chandrasekaran a Third Term as Executive Chairman One of India's most powerful corporate positions looks set to stay in familiar hands. N Chandrasekaran, the executive chairman of Tata Sons, is widely expected to be reappointed for a third term at the helm of the salt-to-softwa...

How One Blog Post Crashed IBM's Stock by 13% in a Single Day

access_time 2026-02-26T16:31:19.08Z face Baaten Bazar Ki (BBK)
How One Blog Post Crashed IBM's Stock by 13% in a Single Day IBM's Stock by 13% in a Single Day On February 23, 2026, IBM had one of the worst days in its modern history. Its stock fell 13.2% - the biggest single-day drop the company had seen since October 2000. In dollar terms, that one drop wiped ...

Banks Told to Stop Pushing Unnecessary Products on Customers

access_time 2026-02-26T16:25:41.903Z face Baaten Bazar Ki (BBK)
Banks Told to Stop Pushing Unnecessary Products on Customers Banks Told to Stop Pushing Unnecessary Products on Customers India's Finance Minister Nirmala Sitharaman has had enough. She wants banks to get back to doing what banks are supposed to do - take deposits and give loans - and stop pestering...

NSE's New Gold Futures Contract: Everything You Need to Know

access_time 2026-02-24T11:36:48.291Z face Baaten Bazar Ki (BBK)
NSE's New Gold Futures Contract Everything You Need to Know If you've ever wanted to trade gold on the stock exchange but found the contract sizes too large, NSE has something new coming your way. Starting March 16, 2026, the National Stock Exchange will launch a 10-gram gold futures contract in its...

Novartis Sells Its India Business to Private Equity Group for ₹1,446 Crore

access_time 2026-02-23T10:47:18.673Z face Baaten Bazar Ki (BBK)
Novartis Sells Its India Business to Private Equity Group for ₹1,446 Crore Novartis Sells Its India Business to Private Equity Group for ₹1,446 Crore Swiss pharmaceutical giant Novartis has decided to walk away from its listed Indian subsidiary. The company has struck a deal to sell its entire 70.68...